CHNG
Change Healthcare Inc
Change Healthcare Inc historical holders
total: 4
Greenlight Capital Change Healthcare Inc transactions over time
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 11 quarters
- Latest activity:
- 2022 Q4
David Einhorn has been an institutional investor in Change Healthcare Inc (CHNG) since 2020 Q1. According to 2026 Q1 report, David Einhorn doesn't hold any shares. The fund/company first acquired CHNG in 2020 Q1, initially purchasing about 5.29M shares. Since the initial investment, Greenlight Capital has made 10 more transactions in this position.
When did David Einhorn exit their CHNG position?
David Einhorn no longer holds Change Healthcare Inc (CHNG). They sold off their entire position in 2022 Q4, closing out an investment that began in 2020 Q1.
When did David Einhorn first invest in CHNG?
David Einhorn first invested in Change Healthcare Inc (CHNG) in 2020 Q1 at the reported quarter-end price of $9.99 per share, acquiring 5,294,005 shares in their initial purchase.
What is David Einhorn's average cost basis for CHNG?
Based on historical transaction data, David Einhorn's estimated cost basis for Change Healthcare Inc (CHNG) is approximately $10.60 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $10.60
- Weighted AVG sell price:
- $23.52
CHNG transactions history by Greenlight Capital
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$27.49
|
|
-100% (-801,701)
|
-1.56%
|
|
2022 Q3
|
1.56%
|
801,701
|
$27.49
|
$22,039,000
|
-45.35% (-665,174)
|
-1.42%
|
|
2022 Q2
|
2.63%
|
1,466,875
|
$23.06
|
$33,825,000
|
-60.84% (-2,278,830)
|
-3.34%
|
|
2022 Q1
|
5.19%
|
3,745,705
|
$21.80
|
$81,655,000
|
+2.99% (+108,900)
|
+0.15%
|
|
2021 Q4
|
4.73%
|
3,636,805
|
$21.38
|
$77,755,000
|
+1.39% (+50,000)
|
+0.07%
|
|
2021 Q3
|
5.04%
|
3,586,805
|
$20.94
|
$75,108,000
|
+3.93% (+135,660)
|
+0.19%
|
|
2021 Q1
|
5.31%
|
3,451,145
|
$22.10
|
$76,271,000
|
-28.74% (-1,391,860)
|
-1.88%
|
|
2020 Q4
|
5.51%
|
$18.65
|
-8.51% (-450,500)
|
|||
|
2020 Q3
|
6.34%
|
$14.51
|
-1.21% (-64,700)
|
|||
|
2020 Q2
|
6.56%
|
$11.20
|
+1.21% (+64,200)
|
|||
|
2020 Q1
|
7.60%
|
$9.99
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.